Literature DB >> 18580265

Efficacy of contact lens systems against recent clinical and tap water Acanthamoeba isolates.

Megan E Shoff1, Charlotte E Joslin, Elmer Y Tu, Laura Kubatko, Paul A Fuerst.   

Abstract

PURPOSE: A recent increase in Acanthamoeba keratitis (AK) cases has been associated with Complete MoisturePlus, although many cases used other solutions. Complete MoisturePlus contains taurine and hydroxypropyl methylcellulose, unlike other multipurpose solutions (MPSs). The purpose of this study is to (1) determine contact lens solution efficacy against recent clinical and tap water Acanthamoeba isolates and (2) determine whether taurine inclusion increases Acanthamoeba survival against contact lens solutions.
METHODS: Acanthamoeba T4 trophozoites from recent AK clinical and tap water isolates were placed on multiple concentrations of taurine-saline agar for 72 hours with Enterobacter aerogenes as prey. Amoebae were exposed for 6 and 24 hours to hydrogen peroxide solutions and MPSs (ReNu Multiplus, Complete MoisturePlus, AMO Trade Name, Opti-free Express, Clear Care, and UltraCare) and tested for survival. Plates were examined over the following week for growth.
RESULTS: Strain type and solution affected survival. MPSs were ineffective, with 100% survival of all strains at 6-hour exposure. Hydrogen peroxide systems were more effective, with survival of 3/5 strains (Clear Care) and 1/5 strains (UltraCare) at 6 hours. The Chicago-area tap water strain was most resistant. Among hydrogen peroxide systems, no statistically significant difference in Acanthamoeba survival existed with taurine inclusion.
CONCLUSIONS: Recent clinical and tap water Acanthamoeba strains, representing proven human pathogens and/or household strains, were highly virulent against contact lens solutions. The Chicago-area tap water strain was most resilient, a concern if tap water is contributing to the AK increase. Results further differentiated resistance among T4 strains, highlighting the importance of multiple strain testing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580265     DOI: 10.1097/QAI.0b013e31815e7251

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  16 in total

1.  Prevalence of Acanthamoeba spp. and other free-living amoebae in household water, Ohio, USA--1990-1992.

Authors:  Lauren J Stockman; Carolyn J Wright; Govinda S Visvesvara; Barry S Fields; Michael J Beach
Journal:  Parasitol Res       Date:  2010-10-27       Impact factor: 2.289

Review 2.  War on terror cells: killing the host that harbours 'superbugs' is an infection control strategy in our fight against infectious diseases.

Authors:  Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  Pathog Glob Health       Date:  2014-01-14       Impact factor: 2.894

3.  Recent outbreaks of atypical contact lens-related keratitis: what have we learned?

Authors:  Elmer Y Tu; Charlotte E Joslin
Journal:  Am J Ophthalmol       Date:  2010-11       Impact factor: 5.258

4.  Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.

Authors:  T Martín-Pérez; T Lozano-Cruz; A Criado-Fornelio; P Ortega; R Gómez; F J de la Mata; J Pérez-Serrano
Journal:  Parasitol Res       Date:  2019-05-08       Impact factor: 2.289

5.  Genotypic identification of Acanthamoeba sp. isolates associated with an outbreak of acanthamoeba keratitis.

Authors:  Gregory C Booton; Charlotte E Joslin; Megan Shoff; Elmer Y Tu; Daryl J Kelly; Paul A Fuerst
Journal:  Cornea       Date:  2009-07       Impact factor: 2.651

6.  Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions.

Authors:  Stephanie P Johnston; Rama Sriram; Yvonne Qvarnstrom; Sharon Roy; Jennifer Verani; Jonathan Yoder; Suchita Lorick; Jacquelin Roberts; Michael J Beach; Govinda Visvesvara
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

7.  Inactivation of Acanthamoeba spp. and Other Ocular Pathogens by Application of Cold Atmospheric Gas Plasma.

Authors:  Wayne Heaselgrave; Gilbert Shama; Peter W Andrew; Michael G Kong
Journal:  Appl Environ Microbiol       Date:  2016-05-02       Impact factor: 4.792

8.  Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.

Authors:  Alfonso Martín Cabello-Vílchez; Carmen M Martín-Navarro; Atteneri López-Arencibia; María Reyes-Batlle; Ines Sifaoui; Basilio Valladares; José E Piñero; Jacob Lorenzo-Morales
Journal:  Parasitol Res       Date:  2013-11-22       Impact factor: 2.289

9.  Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and application of statins as a novel effective therapeutic approach against Acanthamoeba infections.

Authors:  Carmen María Martín-Navarro; Jacob Lorenzo-Morales; Rubén P Machin; Atteneri López-Arencibia; José Manuel García-Castellano; Isabel de Fuentes; Brendan Loftus; Sutherland K Maciver; Basilio Valladares; José E Piñero
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 10.  Genotype distribution of Acanthamoeba in keratitis: a systematic review.

Authors:  Maria Luisa Nunes Diehl; Júlia Paes; Marilise Brittes Rott
Journal:  Parasitol Res       Date:  2021-08-05       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.